Skip to main content

16 Result(s)

within R. Mantegazza Remove this filter

and

  1. Article

    Open Access

    Development and validation of the Myasthenia Gravis TeleScore (MGTS)

    The aim of our study was to validate the Myasthenia Gravis TeleScore (MGTS), a scale for the evaluation of MG patients in telemedicine.

    F. Pasqualin, S. V. Guidoni, E. Albertini, M. Ermani… in Neurological Sciences (2022)

    Download PDF (824 KB) View Article

  2. No Access

    Article

    Italian recommendations for Lambert–Eaton myasthenic syndrome (LEMS) management

    Lambert–Eaton myasthenic syndrome (LEMS) is a pre-synaptic disorder of the neuromuscular and autonomic transmission mediated by antibodies to voltage-gated calcium channels at the motor nerve terminal. LEMS is...

    A. Evoli, R. Liguori, A. Romani, R. Mantegazza, A. Di Muzio… in Neurological Sciences (2014)

  3. No Access

    Article

    Marked phenotypic variability in two siblings with congenital myasthenic syndrome due to mutations in MUSK

    Lorenzo Maggi, R. Brugnoni, V. Scaioli, T. L. Winden, L. Morandi… in Journal of Neurology (2013)

  4. No Access

    Article

    Myasthenia gravis remission and anti-AChR ab reduction after immunosuppressive and anti-neoplastic therapy in a patient with thymic Hodgkin’s disease

    M. T. Ferrò, T. Riccardi, A. Montanelli, P. Bernasconi… in Journal of Neurology (2006)

  5. No Access

    Article

    Is the CACNA1A gene involved in familial migraine with aura?

    The discovery of mutations in the neural calcium channel (CACNA1A) gene in familial hemiplegic migraine (FHM), variant of migraine with aura, led to the suggestion that this gene might be involved in familial ...

    R. Brugnoni, M. Leone, A. Rigamonti, E. Moranduzzo, F. Cornelio… in Neurological Sciences (2002)

  6. No Access

    Chapter

    Immunotherapy of Myasthenia Gravis

    Myasthenia gravis (MG) is an acquired autoimmune disease of the neuromuscular junction mediated by antibodies against the nicotinic acetylcholine receptor (anti-AChR Ab). Anti-AChR Ab, by cross-linking AChR mo...

    C. Antozzi, F. Baggi, F. Andreetta, M. Milani… in Autoantibodies in Neurological Diseases (2002)

  7. No Access

    Chapter

    Idiopathic Inflammatory Myopathies: Immunological Aspects

    Muscle inflammation is generally termed “myositis” whether the aetiology is known (viral, bacterial or parasitic) or unknown (idiopathic). The inflammatory myopathies are a heterogeneous group of subacute/chro...

    R. Mantegazza, P. Bernasconi, F. Cornelio in Autoantibodies in Neurological Diseases (2002)

  8. No Access

    Chapter

    Epilepsy and Autoantibodies

    For many years the central nervous system (CNS) has been considered an immune privileged site, since alloengraftment within the CNS induced a poor immune response. This weak response was explained by: (1) the ...

    P. Bernasconi, T. Granata, F. Baggi… in Autoantibodies in Neurological Diseases (2002)

  9. No Access

    Chapter

    Oral Administration of Peptide Tαl46-162 Prevents EAMG in Mice

    Myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular junction in which antibodies to the acetylcholine receptor (anti-AChR Ab) lead to muscle weakness and fatigability [1]. MG is treated with ...

    F. Baggi, F. Andreetta, E. Caspani, M. Milani, O. Simonicini… in Myasthenia Gravis (2000)

  10. No Access

    Article

    Epidemiological study of myasthenia gravis in the province of Reggio Emilia, Italy

    We carried out a retrospective incidence, prevalence and mortality survey of myasthenia gravis in the province of Reggio Emilia in Northern Italy. Based on 49 patients, the mean incidence per year for the peri...

    D. Guidetti, R. Sabadini, S. Cavalletti, M. Lodesani… in European Journal of Epidemiology (1998)

  11. No Access

    Article

    A new non-radioactive method for the screening and prenatal diagnosis of myotonic dystrophy patients

    Myotonic dystrophy (DM) is an autosomal dominant neuromuscular disease with an estimated incidence of 1 in 8000 and is the most common form of muscular dystrophy affecting adults. An unstable, untranslated pa...

    Raffaella Brugnoni, Lucia Morandi, Bruno Brambati… in Journal of Neurology (1998)

  12. No Access

    Article

    Inflammatory myopathies and systemic disorders: a review of immunopathogenetic mechanisms and clinical features

    The inflammatory myopathies are a heterogeneous group of muscle diseases characterized by muscle degeneration mediated by inflammatory processes. They may be idiopathic, as in polymyositis, dermatomyositis an...

    R. Mantegazza, P. Bernasconi, Paolo Confalonieri… in Journal of Neurology (1997)

  13. Article

    Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain

    L. Harms, A. Bock, W. JÄnisch, J. Valdueza, J. Weber, I. Link… in Journal of Neurology (1994)

    Download PDF (23435 KB)

  14. No Access

    Article

    A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy

    A multicentre retrospective study was carried out on the characteristics and course of myasthenia gravis (MG) in Italy. Data from 1152 patients, fairly representative of the myasthenic population seeking medic...

    R. Mantegazza, E. Beghi, D. Pareyson, C. Antozzi, D. Peluchetti… in Journal of Neurology (1990)

  15. No Access

    Article

    Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis

    Azathioprine (Aza) has been used alone or in combination with steroids for two groups of myasthenic patients. Positive responses were noted in 75% of patients on Aza alone and in 70% receiving the combined reg...

    R. Mantegazza, C. Antozzi, D. Peluchetti, A. Sghirlanzoni… in Journal of Neurology (1988)

  16. No Access

    Article

    Thymectomy for myasthenia gravis: a fourteen-year experience

    Over the last 14 years we have thymectomized 106 myasthenic patients, 62 by transcervical and 44 by transsternal approach. At the end of the follow-up 49 patients (46,2%) had improved, 12 of these (11,2%) bein...

    Dr A. Sghirlanzoni, R. Mantegazza… in The Italian Journal of Neurological Scienc… (1985)